Eli Lilly Quintuple Agonist: Five Receptors, Greater Weight Loss Than Retatrutide
Eli Lilly is presenting animal data at ADA 2026 on a long-acting quintuple agonist that hits five receptors — GLP-1, GIP, glucagon, amylin, and calcitonin — and outperforms retatrutide in obese rats. Tony Huge breaks down the biochemistry, why it matters, and how it stacks with old-school rapid fat loss protocols.
IGF-1 LR3: My 10-Day Burst Protocol for Direct Receptor Activation
My field-tested IGF-1 LR3 burst protocol from 2016. 100mcg/day for 10 days, sodium chloride water reconstitution, calorie cycle the days. The receptor science behind why short pulses beat continuous cycles, plus stacking with BPC-157, TB-500, and MK-677 during the off-window.
Connor McGregor, Brett Favre, and the Celebrity Ibogaine Moment
Connor McGregor. Brett Favre. Keith Jardine. Marcus Luttrell in the Oval Office. The elite athletes and combat operators who broke the ibogaine taboo in public and created the cultural permission structure that made Trump’s executive order politically possible.
The 2024 Stanford Study: Magnesium-Ibogaine for Veterans With TBI (What It Proved)
Thirty US Special Operations veterans with traumatic brain injury. One magnesium-ibogaine session. Eighty-eight percent reduction in PTSD symptoms. The Stanford Nature Medicine paper that rewrote the political conversation on plant medicine.
Ibogaine vs Methadone vs Suboxone: Why Addiction Medicine Is About to Be Disrupted
Methadone replaces heroin with heroin-lite. Suboxone replaces opioids with another opioid. Both are maintenance businesses dressed up as medicine. Ibogaine, the compound Trump’s executive order just fast-tracked, resets the receptor system in a single night and reports outcomes neither can touch.
Right to Try and Ibogaine: What Trump’s Executive Order Actually Unlocks
Trump’s executive order does five specific things. It does not legalize ibogaine. A clear-eyed breakdown of what actually changes: Right to Try pathway, National Priority Voucher review, investigational new drug clearance, $50M state research, and the realistic timeline for legal US clinics.
Ibogaine Cardiac Safety: The Real Risk Profile and How Legitimate Clinics Handle It
Ibogaine has real cardiac risks. They are manageable. Most of the deaths in the literature occurred in unmonitored settings without screening. A clear-eyed breakdown of the QT prolongation mechanism, what legitimate clinics do, and the exact checklist that would have flagged the tragedy that put Ameen Alai in prison.
Guru Ameen Starts 48 Months for Ibogaine — And Within 6 Months, RFK Jr. Will Make Everything He Did Legal
Ameen got 48 months. The federal judge declared ibogaine ‘more dangerous than fentanyl’ on the sentencing record. The same month Texas launched a $50 million ibogaine research program and Netflix dropped a documentary showing Navy SEALs credit the molecule with saving their lives. My prediction, on the record: within six months, the Trump administration issues executive action. And then we fight for the pardon.
The Compound That Cured My Brain Fog in 30 Days: My Microdose Ibogaine Experiment Under Guru Ameen
I’ve been microdosing ibogaine under my friend Guru Ameen Alai’s direct supervision for the past year. Here’s what six years of knowing him, thirty days of protocol, and one federal indictment have taught me about the most undervalued molecule in addiction medicine.
They’re Trying to Crucify Guru Ameen for Healing People: Stanford Just Proved He Was Right
Fifteen months after I first wrote about my friend Guru Ameen’s federal case, the ‘resulting in death’ charge has collapsed — exactly as I predicted. Meanwhile, Stanford just published an 88% PTSD reduction result with ibogaine in combat veterans, and an unprecedented political coalition is forming. The dam is about to break.